Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyruvate kinase activators for use in treating blood disorders

Pyruvate kinase activators for use in treating blood disorders

US Patent 12133853 · Granted Nov 5, 2024

Estimated economic value: $37,390,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KRas inhibitors2025
Carrier for olefin polymerization catalyst, and preparation method therefor and 2025
Water-soluble ynamide coupling reagent and preparation method and use thereof2024
Heterocyclic compounds and uses thereof2024
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel d2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Catalyst component and catalyst for olefin polymerization, and application there2024
Inhibitors of cellular metabolic processes2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024